Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth
- PMID: 26794032
- PMCID: PMC4931731
- DOI: 10.1089/AID.2015.0281
Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth
Abstract
The aim of this study was to evaluate the association of in utero exposure to highly active antiretroviral therapy (HAART) with left ventricular (LV) function and structure in HIV-exposed uninfected (HEU) children. A prospective, multisite cohort study in HEU children was conducted by the Pediatric HIV/AIDS Cohort Study (PHACS). Echocardiographic measures of LV systolic and diastolic function and cardiac structure were obtained from HEU subjects aged ≥6 years enrolled in the PHACS Surveillance Monitoring of ART Toxicities study. Echocardiographic Z-scores were calculated using normative data from an established reference cohort. We used adjusted linear regression models to compare Z-scores for echocardiographic measures from HEU children exposed in utero to HAART with those exposed to non-HAART, adjusting for demographic and maternal health characteristics. One hundred seventy-four HEU subjects with echocardiograms and maternal ARV information were included (mean age 10.9 years; 48% male, 56% black non-Hispanic). Among 156 HEU youth with any ARV exposure, we observed no differences in Z-scores for LV systolic function measures between youth exposed in utero to HAART (39%) and HAART-unexposed youth in either unadjusted or adjusted models. In adjusted models, those exposed to HAART had significantly lower mitral late diastolic inflow velocities (adjusted mean Z-score = 0.00 vs. 0.52, p = .04) and significantly higher adjusted mean LV mass-to-volume ratio Z-scores (adjusted mean Z-score = 0.47 vs. 0.11, p = .03) than HAART-unexposed youth. Uninfected children with perinatal exposure to HAART had no difference in LV systolic function. However, small but significant differences in LV diastolic function and cardiac structure were observed, suggesting that continued monitoring for cardiac outcomes is warranted in this population.
Figures
Similar articles
-
Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.AIDS. 2015 Jan 2;29(1):91-100. doi: 10.1097/QAD.0000000000000499. AIDS. 2015. PMID: 25562493 Free PMC article.
-
Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy.AIDS. 2020 Mar 15;34(4):529-537. doi: 10.1097/QAD.0000000000002443. AIDS. 2020. PMID: 31764073 Free PMC article.
-
Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.J Am Coll Cardiol. 2017 Oct 31;70(18):2240-2247. doi: 10.1016/j.jacc.2017.09.008. J Am Coll Cardiol. 2017. PMID: 29073951 Free PMC article.
-
Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.Curr Opin HIV AIDS. 2016 Sep;11(5):465-476. doi: 10.1097/COH.0000000000000300. Curr Opin HIV AIDS. 2016. PMID: 27716731 Review.
-
Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis.Lancet Child Adolesc Health. 2022 Jun;6(6):393-408. doi: 10.1016/S2352-4642(22)00071-2. Epub 2022 Apr 26. Lancet Child Adolesc Health. 2022. PMID: 35483380 Free PMC article.
Cited by
-
Complications of Treatment in Youth with HIV.Curr HIV/AIDS Rep. 2016 Aug;13(4):226-33. doi: 10.1007/s11904-016-0320-1. Curr HIV/AIDS Rep. 2016. PMID: 27234970 Free PMC article. Review.
-
Left Ventricular Changes and Inflammatory Biomarkers in HIV-Exposed Uninfected Infants in Jos, Northcentral Nigeria.Pediatr Cardiol. 2025 Aug 25. doi: 10.1007/s00246-025-03925-2. Online ahead of print. Pediatr Cardiol. 2025. PMID: 40853460
-
Direct and indirect cardiovascular and cardiometabolic sequelae of the combined anti-retroviral therapy on people living with HIV.Front Physiol. 2023 Mar 27;14:1118653. doi: 10.3389/fphys.2023.1118653. eCollection 2023. Front Physiol. 2023. PMID: 37078025 Free PMC article. Review.
-
Letter to the Editor: Cardiac Dysfunction Among Youth With Perinatal HIV Acquisition and Exposure.J Acquir Immune Defic Syndr. 2024 Mar 1;95(3):e2-e4. doi: 10.1097/QAI.0000000000003353. J Acquir Immune Defic Syndr. 2024. PMID: 38408218 Free PMC article. No abstract available.
-
In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals.Congenit Heart Dis. 2016 Jul;11(4):309-14. doi: 10.1111/chd.12374. Epub 2016 May 20. Congenit Heart Dis. 2016. PMID: 27205889 Free PMC article.
References
-
- Lipshultz SE, Easley KA, Orav EJ, et al. : Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 2000;343:759–766 - PubMed
-
- Blanche S, Tardieu M, Rustin P, et al. : Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084–1089 - PubMed
-
- Lipshultz SE, Shearer WT, Thompson B, et al. : Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol 2011;57:76–85 - PMC - PubMed
-
- Lipshultz SE, Williams PL, Wilkinson JD, Leister EC, Van Dyke RB, Shearer WT, et al. ; for the Pediatric HIV/AIDS Cohort Study (PHACS). Cardiac status of HIV-infected children treated with long-term combination antiretroviral therapy: Results from the Adolescent Master Protocol of the NIH Multicentre Pediatric HIV/AIDS Cohort study (PHACS). JAMA Pediatr 2013;167:520–527 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical